SCHEMBL7259369

SCHEMBL7259369

NCCc1ccc(O)c(NC=O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 4/20 0.55
TAAR1 Q96RJ0 4/20 0.55
MAPK1 P28482 3/20 0.55
KDM4E B2RXH2 3/20 0.55
SLC6A2 P23975 3/20 0.55
ADRB2 P07550 3/20 0.55
MAPT P10636 2/20 0.55
DRD2 P14416 2/20 0.55
DRD1 P21728 2/20 0.55
DRD4 P21917 2/20 0.55
DRD5 P21918 2/20 0.55
DRD3 P35462 2/20 0.55
RECQL P46063 2/20 0.55
SLC6A3 Q01959 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
APEX1 P27695 2/20 0.55
ALDH1A1 P00352 2/20 0.55
HTR1A P08908 2/20 0.55
ADRA1A P35348 2/20 0.55
TP53 P04637 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10410169 0.87 TAAR1 (0.55) ADRA2ATAAR1MAPK1KDM4ESLC6A2
SCHEMBL6812666 0.83 KDM5A (0.50) ADRA2AMAPK1ADRB2DRD2DRD3
SCHEMBL6475595 0.81 KDM5A (0.47) ADRA2AMAPK1ADRB2DRD2DRD3
SCHEMBL11247792 0.81 KDM5A (0.55) MAPK1ADRB2DRD2DRD3SLC6A3
SCHEMBL13074401 0.79 KDM5A (0.53) ADRA2AMAPK1KDM4EADRB2MAPT
Hydrochloric Acid SCHEMBL11670336 0.78 ADRB2 (0.55) ADRA2AKDM4ESLC6A2ADRB2MAPT
SCHEMBL10925191 0.77 KDM5A (0.44) ADRA2AMAPK1ADRB2DRD2DRD3
SCHEMBL11170458 0.77 KDM5A (0.58) MAPK1KDM4EADRB2MAPTDRD2
SCHEMBL10410168 0.77 MAPK1 (0.55) ADRA2ATAAR1MAPK1KDM4ESLC6A2
SCHEMBL10409066 0.76 DRD2 (0.61) KDM4EDRD2DRD1DRD4DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003042160-A1 ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONISTS THERAVANCE, INC. (US) 2003-05-22 WO claimed
WO-1986001204-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1986-02-27 WO claimed
US-4958026-A HYPOTENSIVE AGENTS SCHERING AKTIENGESLLSCHAFT (DE) 1990-09-18 US disclosed
EP-0189473-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS. SCHERING AG (DE) 1986-08-06 EP disclosed
WO-1986001204-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1986-02-27 WO disclosed